10X GENOMICS INC-CLASS A (TXG) Stock Price, Quote, News and Overview
NASDAQ:TXG - Nasdaq - US88025U1097 - Common Stock - Currency: USD
TXG Quote, Performance and Key Statistics
10X GENOMICS INC-CLASS A
NASDAQ:TXG (2/10/2025, 8:27:20 PM)
After market: 12.11 +0.05 (+0.41%)12.06
-2.19 (-15.37%)
The current stock price of TXG is 12.06 USD. In the past month the price decreased by -22.59%. In the past year, price decreased by -75.11%.
TXG Latest News and Analysis
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
Ark Invest made significant trades on Friday, including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made.
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox
Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The aggressive growth fund investor has slowed her shopper this holiday season, but she still made time to build up some of her existing positions.
TXG Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 25.29 | 211.47B | ||
| DHR | DANAHER CORP | 27.17 | 146.98B | ||
| A | AGILENT TECHNOLOGIES INC | 27.16 | 40.98B | ||
| IQV | IQVIA HOLDINGS INC | 18.58 | 37.57B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 32.57 | 28.28B | ||
| WAT | WATERS CORP | 35.78 | 24.20B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 47.95 | 23.47B | ||
| ILMN | ILLUMINA INC | 42.85 | 16.65B | ||
| ICLR | ICON PLC | 13.6 | 15.76B | ||
| RVTY | REVVITY INC | 23.44 | 13.98B | ||
| AVTR | AVANTOR INC | 19.01 | 12.94B | ||
| TECH | BIO-TECHNE CORP | 38.63 | 11.11B |
Related stock screener links
About TXG
Company Profile
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. The company is headquartered in Pleasanton, California and currently employs 1,259 full-time employees. The company went IPO on 2019-09-12. The firm's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.
Company Info
10X GENOMICS INC-CLASS A
6230 Stoneridge Mall Road
Pleasanton CALIFORNIA 94588 US
CEO: Serge Saxonov
Employees: 1259
Company Website: https://www.10xgenomics.com/
Investor Relations: https://investors.10xgenomics.com/
Phone: 19254017300
TXG FAQ
What is the stock price of TXG?
The current stock price of TXG is 12.06 USD.
What is the symbol for 10X GENOMICS INC-CLASS A stock?
The exchange symbol of 10X GENOMICS INC-CLASS A is TXG and it is listed on the Nasdaq exchange.
On which exchange is TXG stock listed?
TXG stock is listed on the Nasdaq exchange.
Is TXG a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for TXG, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of TXG.
Does TXG stock pay dividends?
TXG does not pay a dividend.
When does TXG stock report earnings?
TXG will report earnings on 2025-02-12, after the market close.
What is the Price/Earnings (PE) ratio of TXG?
TXG does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.53).
What is the Short Interest ratio of TXG stock?
The outstanding short interest for TXG is 7.32% of its float.
TXG Technical Analysis
TXG Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to TXG. While TXG has a great health rating, there are worries on its profitability.
TXG Financial Highlights
Over the last trailing twelve months TXG reported a non-GAAP Earnings per Share(EPS) of -1.53. The EPS decreased by 19.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -19.47% | ||
| ROE | -25.26% | ||
| Debt/Equity | 0 |
TXG Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 74% to TXG. The Buy consensus is the average rating of analysts ratings from 23 analysts.
For the next year, analysts expect an EPS growth of 34.1% and a revenue growth -2% for TXG